ScoreWhy is Qingdao Vland Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 8.40% and Operating profit at 1.41% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.2 times
- OPERATING PROFIT(Q) Lowest at CNY 27.06 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 7.44 %
3
With ROE of 4.90%, it has a expensive valuation with a 1.99 Price to Book Value
- Over the past year, while the stock has generated a return of 15.88%, its profits have fallen by -13.3%
- At the current price, the company has a high dividend yield of 0.6
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Qingdao Vland Biotech Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Qingdao Vland Biotech Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Qingdao Vland Biotech Co., Ltd.
8.41%
0.27
36.42%
China Shanghai Composite
13.33%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.40%
EBIT Growth (5y)
1.41%
EBIT to Interest (avg)
20.12
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.52
Tax Ratio
25.12%
Dividend Payout Ratio
40.39%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.16%
ROE (avg)
7.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
1.99
EV to EBIT
34.21
EV to EBITDA
17.23
EV to Capital Employed
1.85
EV to Sales
2.79
PEG Ratio
NA
Dividend Yield
0.63%
ROCE (Latest)
5.40%
ROE (Latest)
4.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -15.4% (YoY
EPS(Q)
Highest at CNY 0.14
-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.2 times
OPERATING PROFIT(Q)
Lowest at CNY 27.06 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 7.44 %
Here's what is working for Qingdao Vland Biotech Co., Ltd.
EPS
Highest at CNY 0.14
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -15.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Qingdao Vland Biotech Co., Ltd.
Operating Profit
Lowest at CNY 27.06 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 7.44 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debtors Turnover Ratio
Lowest at 3.2 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
